CALGEL

This brand name is authorized in Estonia, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug CALGEL contains a combination of these active pharmaceutical ingredients (APIs):

1 Lidocaine UNII 98PI200987 - LIDOCAINE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. Read about Lidocaine

2 Cetylpyridinium UNII CUB7JI0JV3 - CETYLPYRIDINIUM

Cetylpyridinium is an antiseptic with activity against both gram positive and gram negative organisms. Read about Cetylpyridinium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A01AD11	Various	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1034918
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 38358
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100250099, 100363780, 100371466, 100393172, 100440629
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64911001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522345311